1. Home
  2. Labeler Index
  3. Athenex Pharmaceutical Division, Llc.
  4. 70860-305
  5. NDC Package Code: 70860-305-51 Eptifibatide

NDC Package 70860-305-51 Eptifibatide

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70860-305-51
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 100 mL in 1 VIAL, SINGLE-DOSE
Product Code:
70860-305
Proprietary Name:
Eptifibatide
Usage Information:
Treatment with eptifibatide is contraindicated in patients with: A history of bleeding diathesis, or evidence of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another parenteral GP IIb/IIIa inhibitor Dependency on renal dialysis Hypersensitivity to eptifibatide or any component of the product (hypersensitivity reactions that occurred included anaphylaxis and urticaria)
11-Digit NDC Billing Format:
70860030551
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Labeler Name:
Athenex Pharmaceutical Division, Llc.
Sample Package:
No
FDA Application Number:
ANDA213081
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
09-30-2022
End Marketing Date:
08-31-2024
Listing Expiration Date:
08-31-2024
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70860-305-51?

The NDC Packaged Code 70860-305-51 is assigned to a package of 1 vial, single-dose in 1 carton / 100 ml in 1 vial, single-dose of Eptifibatide, labeled by Athenex Pharmaceutical Division, Llc.. The product's dosage form is and is administered via form.

Is NDC 70860-305 included in the NDC Directory?

No, Eptifibatide with product code 70860-305 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Athenex Pharmaceutical Division, Llc. on September 30, 2022 and its listing in the NDC Directory is set to expire on August 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70860-305-51?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 70860-305-51?

The 11-digit format is 70860030551. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270860-305-515-4-270860-0305-51